J&J aims to 'save legs, change lives' with new peripheral artery disease awareness effort
Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. | Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. But the disease can be silent, so millions of Americans—especially Black Americans—don’t know they have it until it’s too late. Johnson & Johnson’s Janssen unit is hoping to change that with a new awareness initiative.
ESVM Guideline on peripheral arterial disease
Peripheral Artery Disease National Action Plan
Save Legs. Change Lives.™ Paves the Way for Change
Lower extremity amputation protocol: a pilot enhanced recovery
New Janssen initiative aims to advance equitable care and address
Our Race to Health Equity
Amy Carmen-Hall on LinkedIn: National Peripheral Artery Disease
About Us Save Legs. Change Lives™
Activating Our Commitment to Health Equity - Johnson & Johnson We
Revolutionary Solutions: Improving Outcomes for Peripheral Artery
